Results
|
61.
|
|
|
62.
|
|
|
63.
|
|
|
64.
|
|
|
65.
|
|
|
66.
|
|
|
67.
|
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis. [electronic resource] by
- Collin, C
- Ehler, E
- Waberzinek, G
- Alsindi, Z
- Davies, P
- Powell, K
- Notcutt, W
- O'Leary, C
- Ratcliffe, S
- Nováková, I
- Zapletalova, O
- Piková, J
- Ambler, Z
Producer: 20100929
In:
Neurological research vol. 32
Availability: No items available.
|
|
68.
|
|
|
69.
|
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis. [electronic resource] by
- Havrdova, E
- Zivadinov, R
- Krasensky, J
- Dwyer, M G
- Novakova, I
- Dolezal, O
- Ticha, V
- Dusek, L
- Houzvickova, E
- Cox, J L
- Bergsland, N
- Hussein, S
- Svobodnik, A
- Seidl, Z
- Vaneckova, M
- Horakova, D
Producer: 20091008
In:
Multiple sclerosis (Houndmills, Basingstoke, England) vol. 15
Availability: No items available.
|
|
70.
|
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. [electronic resource] by
- Novotna, A
- Mares, J
- Ratcliffe, S
- Novakova, I
- Vachova, M
- Zapletalova, O
- Gasperini, C
- Pozzilli, C
- Cefaro, L
- Comi, G
- Rossi, P
- Ambler, Z
- Stelmasiak, Z
- Erdmann, A
- Montalban, X
- Klimek, A
- Davies, P
Producer: 20120403
In:
European journal of neurology vol. 18
Availability: No items available.
|
|
71.
|
An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies. [electronic resource] by
- Mauser-Bunschoten, E P
- Kleine Budde, I
- Lopaciuk, S
- Koopman, M M W
- Van Der Meer, F J M
- Novàkovà, I R O
- Ypma, P
- Van Der Linden, P W G
- Windyga, J
- Strengers, P F W
Producer: 20110812
In:
Haemophilia : the official journal of the World Federation of Hemophilia vol. 17
Availability: No items available.
|
|
72.
|
In vivo recovery and safety of human factor VIII product AAFACT in patients with haemophilia A. [electronic resource] by
- Vossebeld, P J M
- Tissing, M H
- Van Den Berg, H M
- Leebeek, F W G
- De Goede-Bolder, A
- NovAkovA, I R O
- Gerrits, W B J
- Peters, M
- Koopman, M M W
- Faber, A
- Hiemstra, H
- Grob, P
- Strengers, P F W
Producer: 20030501
In:
Haemophilia : the official journal of the World Federation of Hemophilia vol. 9
Availability: No items available.
|